Tacoloy, Rishal .
HRN: 28-65-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2026
CEFUROXIME 500MG (TAB)
04/03/2026
04/10/2026
PO
500
Bid
S/p Nsvd With RMLE
Pending Pharmacy Acceptance
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: